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Abstract

In an effort to probe whether the metal content of metallo-β-lactamase L1 is affected by metal ion
bioavailability, L1 was overexpressed as mature protein (M-L1) and full-length (FL-L1) analogues, and the
analogues were characterized with metal analyses, kinetics, and EPR spectroscopy. FL-L1, containing the
putative leader sequence, was localized in the periplasm of Escherichia coli and shown to bind Zn(II)
preferentially. The metal content of FL-L1 could be altered if the enzyme was overexpressed in minimal medium
containing Fe and Mn, and surprisingly, an Fe-binding analogue was obtained. On the other hand, M-L1, lacking
the putative leader sequence, was localized in the cytoplasm of E. coli and shown to bind various amounts of Fe
and Zn(II), and like FL-L1, the metal content of the resulting enzyme could be affected by the amount of metal
ions in the growth medium. L1 was refolded in the presence of Fe, and a dinuclear Fe-containing analogue of L1
was obtained, although this analogue is catalytically inactive. EPR spectra demonstrate the presence of an
antiferromagnetically coupled Fe(III)Fe(II) center in Fe-containing L1 and suggest the presence of a Fe(III)Zn(II)
center in M-L1. Metal analyses on the cytoplasmic and periplasmic fractions of E. coli showed that the
concentration of metal ions in the periplasm is not tightly controlled and increases as the concentration of metal
ions in the growth medium increases. In contrast, the concentration of Zn(II) in the cytoplasm is tightly
controlled while that of Fe is less so.
Bacterial resistance to β-lactam containing antibiotics such as penicillins, cephalosporins, and carbapenems is
most often accomplished by expression of β-lactamases, which hydrolyze the C−N bond of these antibiotics (14). A majority of these β-lactamases utilizes an active site serine group for the nucleophilic attack on the βlactam carbonyl, and the serine β-lactamases have been studied extensively for many years (4). On the other
hand, one class (class B) of β-lactamases utilizes a metal-assisted hydrolysis pathway to inactivate β-lactam
containing antibiotics, and these enzymes are called metallo-β-lactamases (mβl’s) (1, 2, 5-7). The mβl’s have
been further divided into subgroups based on sequence identity, Zn(II) content, substrate preference, and
biochemical properties. Subgroup B1 enzymes require 2 Zn(II) ions for full catalytic activity, exhibit kinetic
preference for penicillins as substrates, exhibit >23% sequence identity toward other subgroup B1 members,
and are represented by mβl’s CcrA from Bacteroides fragilis, BcII from Bacillus cereus, and IMP-1 from various
sources (1, 5). Subgroup B2 enzymes require only 1 Zn(II) ion for full catalytic activity, preferentially hydrolyze
carbapenems, exhibit 11% sequence identity with the subgroup B1 enzymes, and are represented by mβl’s ImiS
from Aeromonas sobria and CphA from Aeronomas hydrophila(1, 5). Subgroup B3 enzymes require 2 Zn(II) ions
for full activity, exhibit a kinetic preference for penicillins, contain only 9 conserved residues with the subgroup
B1 enzymes, and are represented by mβl’s L1 from Stenotrophomonas maltophilia and FEZ-1 from Legionella
gormanii(1, 5). Extensive structural and mechanistic studies have been reported on certain mβl’s, and several
studies reporting nonclinical inhibitors have been reported.

β-Lactam-containing antibiotics are antibacterial because these drugs inactivate transpeptidase, which is an
enzyme that catalyzes the cross-linking of peptidoglycan building blocks to form part of the bacterial cell
wall (4). In order to interact with transpeptidase in Gram-negative bacteria, β-lactam containing antibiotics must
be able to cross the outer membrane and be present in the periplasm (8). Likewise, β-lactamases must be
exported into the extracellular space in Gram-positive bacteria or into the periplasm in Gram-negative bacteria
in order to interact and inactivate the β-lactam containing antibiotics. To mimic the physiological situation, most
recombinant mβl’s are expressed into the periplasm of Escherichia coli by the addition of fusion tags or leader
sequences, and most of the resulting recombinant enzymes have been shown to bind Zn(II) after isolation (1, 5,
7).
Despite significant amino acid sequence divergence, mβl’s contain an αββα motif, and the Zn(II) ions bind in a
pocket contained in the ββ interface (1, 5, 7). For the B1 and B3 mβl’s, one of the Zn(II) ions binds to a site
(called Zn1 site), in which three histidine residues and the bridging hydroxide serve as metal binding ligands. In
all three classes of mβl’s, Zn(II) binds to a site (called Zn2 site) made up of one aspartic acid, one histidine, one
histidine/cysteine, the bridging hydroxide, and a terminally bound water molecule. Previous modeling,
mechanistic, and structural studies have suggested that the β-lactam carbonyl interacts with the Zn(II) in the
Zn1 site (or residues in the Zn1 site for the B2 mβl’s), while the lone pair electrons on the β-lactam nitrogen
coordinate metal ion in the Zn2 site (9-13).
The αββα tertiary fold motif is called the metallo-β-lactamase fold, and there is an increasing number of
proteins that contain this motif, including rubredoxin oxidoreductase (ROO), glyoxalase II, arylsulfatase, cAMP
phosphodiesterase, and tRNA maturase (5). The most common metal ion found in these proteins is Zn(II);
however, glyoxalase II has been reported to bind Fe, Zn, and Mn (14-16), and ROO has been reported to be a
dinuclear Fe protein (17). In addition, Vila and co-workers recently reported that metallo-β-lactamase GOB
from E. meningoseptica when overexpressed as a GST-fusion construct and folded in the cytoplasm of E. coli is
isolated containing various amounts of Zn(II) and iron (18). These results suggest that the localization where a
protein is folded (cytoplasm or periplasm) and the bioavailability of the metal ions in that location play a role in
which metal ions bind to recombinant proteins. To test this suggestion, we constructed an overexpression
plasmid for full-length L1 that contains the S. maltophilia leader sequence (FL-L1) and a plasmid containing
mature L1 that lacked the S. maltophilia leader sequence (M-L1). The resulting overexpression plasmids were
used to produce L1, and the FL-L1 and M-L1 were characterized using metal analyses, steady-state kinetics, and
spectroscopic studies.

Materials and Methods
Cloning
Forward primer, 5′-AAAAA CAT ATG GCC GAA GTA CCA CTG CCG C, and reverse primer, 5′-AAAAA AAG CTT AGC
GGG CCC CG, were purchased from Integrated DNA Technologies. The PCR reactions were carried out with the
following conditions: 95 °C, 90 s; 95 °C, 30 s; 55.5 °C, 30 s; 72 °C, 60 s; 25 cycles. The gel-purified PCR product
and pET26b (Novagen) plasmid were digested with NdeI and HindIII according to manufacturer’s instructions.
The gene that encodes for L1 was ligated into pET26b, and the resulting plasmid (pM-L1) was transformed
into E. coli DH5α and confirmed with DNA sequencing. The pM-L1 plasmid was transformed into E.
coli BL21(DE3)pLysS cells, and the resulting cells were used for overexpression studies.

Antimicrobial Susceptibility Assay
The in vitro activity of ampicillin against L1 (FL-L1, full-length L1) and truncated-L1 (M-L1, mature L1) that was
overexpressed in E. coli BL21(DE3) cells was determined by a disk diffusion susceptibility test. Bacterial cultures
were grown to midlog phase, and protein production was induced by making the cultures 1 mM in

IPTG.1 Cultures were then grown approximately 3 h, and disk diffusion testing was performed by the NCCLS
methodology on Mueller−Hinton agar (Becton-Dickinson) plates (National Committee for Clinical Laboratory,
1997, Performance standards for antimicrobial disk susceptibility tests; approved standard M2-A6. National
Committee for Clinical Laboratory Standards, Wayne, PA). Culture plates were incubated for 16 h, and the zone
diameter sizes were measured. Periplasmic and cytoplasmic accumulation of L1 in both cultures was confirmed
by fractionating cytoplamsic and periplasmic components using a PeriPreps periplasting kit (Epicenter, Madison,
WI).
Abbreviations: ICP-AES, inductively coupled plasma atomic emission spectroscopy; IPTG, isopropyl β-dthiogalactopyranoside; Gdn-HCl, guanidinium chloride; Hepes, 4-(2-hydroxyethyl)-1-piperazineethanesulfonic
acid; FPLC, fast performance liquid chromatography; LB, Luria−Bertani; MALDI-TOF MS, matrix-assisted laser
desorption ionization mass spectrometry; PBS, phosphate-buffered saline; TAT, twin arginine transport.

Overexpression and Purification of L1
A 50 mL overnight preculture of BL21(DE3) E. coli cells containing the pET26b-based plasmid that encodes for ML1 or FL-L1 was used to innoculate 4 × 1 L flasks of LB or minimal medium, and the resulting culture was grown
at 37 °C with shaking until the culture reached an optical density at 600 nm of 0.6−0.8. The cultures were then
cooled to 15 °C for 30 min, made 0.5 mM in IPTG, and shaken overnight at 15 °C (roughly 16 h). For cultures to
which metal ions were added, the metal ions were added at the same time as IPTG was added. The culture was
centrifuged for 15 min (8200g), and the resulting cell pellet was resuspended in 50 mM Hepes, pH 6.0 (buffer A).
The cells were lysed by passing the resuspended cells through a French press three times at a pressure of
1000−1500 psi. After removal of insoluble components by centrifugation (25 min at 23400g), the supernatant
was dialyzed versus buffer A overnight. The dialyzed protein solution was centrifuged (25 min at 23400g) and
subjected to FPLC as previously reported (19). The FPLC fractions were analyzed using SDS−PAGE gels, and
protein bands thought to contain L1 were subjected to in-gel trypsin digestions and peptide identifications using
MALDI-TOF mass spectrometry, as previously reported (20).

Preparation of Metal-Free (Apo) L1
A concentrated solution of L1 (∼ 0.3 mM) was dialyzed against 4 × 1 L of 50 mM Hepes, pH 7.0, containing 10
mM 1,10-phenanthroline and then dialyzed against 6 × 1 L of 50 mM Hepes, pH 7.0. The metal content of the
resulting sample was ascertained by ICP-AES, as previously reported (21). The sample was stored in a −80 οC
freezer.

In Vitro Unfolding and Refolding of L1
Apo-L1 (2 mL, 100 μM) was unfolded in 18 mL of 6 M guanidinium chloride (Gdn-HCl). The sample was incubated
on ice for 1 h and then dialyzed versus 1 L of 50 mM Hepes, pH 7.0, containing no added metal, 50 μM Fe(II),
Mn(II), or Zn (II) or Fe(II) and Zn(II). Refolded L1 was further dialyzed versus 5 × 1 L of Chelex-treated, 50 mM
Hepes, pH 7.0, to remove any unbound metals and remaining Gdn-HCl. The resulting solution was centrifuged
(25 min at 23400g) to remove any precipitates.

Steady-State Kinetics
Steady-state kinetic studies were performed on an Agilent 8453A UV−vis diode array spectrophotometer at 25
°C using nitrocefin as the substrate and 50 mM cacodylate, pH 7.0, as the buffer.

EPR Spectroscopy
EPR spectra were recorded using a Bruker E600 EleXsys spectrometer equipped with an Oxford Instruments
ESR900 helium flow cryostat and ITC503 temperature controller and an ER4116DM cavity operating at 9.63 GHz
in perpendicular mode. Other recording parameters are given in the figure legends. Quantitation of signals was

carried out by double integration of spectra recorded under nonsaturating conditions at 10−12 K. A 2 mM Cu(II)EDTA standard in Hepes, pH 7.5, recorded at 60 K, 50 μW, was used. Integration limits and correction factors
for S = 1/2 and S = 5/2 signals where D is assumed to be small compared to temperature, as employed
elsewhere (22) and recently described explicitly by Bou-Abdallah and Chasteen and references therein (23, 24).

Metal Content in Cytoplasm and Periplasm of E. coli Cells
E. coli BL21 cells were cultured in M9 minimal medium containing no added metal ions or 100 μM Zn(II), Fe(II),
or Mn(II) until reaching an optical density at 600 nm of 1.0. The cells were collected by centrifugation (8 min at
6000g). The resulting cell pellets were washed twice with 5 mL of PBS (137 mM NaCl, 2.7 mM KCl, 1.5 mM
KH2PO4,7.7 mM Na2HPO4, pH 7.4), and cytoplasmic fractions were separated from periplasmic components of
the cell using a PeriPreps periplasting kit (Epicenter, Madison, WI) according to manufacturer’s instructions. The
metal content of the cytoplamsic/periplasmic fractions of the cells was measured using ICP-AES, as previously
reported (21).

Results
S. maltophilia Leader Sequence Leads to L1 Being Exported to and Folded in the
Periplasm of E. coli
The gene for metallo-β-lactamase L1 from pathogen S. maltophilia encodes for a 290 amino acid protein that
contains a 21 amino acid (MRSTLLAFALAVALPAAHTSA) leader sequence (25), which presumably targets the
protein for export into and folding in the periplasm, and a 269 amino acid mature peptide containing the Nterminus of AEVPLPQ (19). To determine if the leader sequence from S. maltophilia is recognized by E. coli and
used to target L1 for export into the periplasm, we generated a pET26b-based overexpression plasmid
containing the L1 gene lacking the leader sequence (M-L1) and used this plasmid to overexpress L1. The
overexpression plasmid containing the gene for L1 and the leader sequence (FL-L1) has previously been
reported (19) and was used as a control in these studies. Both overexpression plasmids were transformed into E.
coli BL21(DE3)pLysS cells, and M-L1 and FL-L1 were overexpressed. The periplasmic fraction of each cell culture
was obtained using the PeriPreps periplasting kit according to manufacturer’s instructions. An SDS−PAGE gel
(Figure 1A), followed by in-gel trypsin digestions/peptide identifications with MALDI-TOF MS, demonstrated that
L1 was only found in the sample that was produced from the overexpression plasmid containing the L1 gene and
the leader sequence. The overexpression plasmid containing the gene for L1 without the leader sequence (M-L1)
produced no L1 in the periplasm of E. coli. SDS−PAGE gels of the boiled cell fractions from the cultures
demonstrated that L1 was overexpressed at similar levels in both cultures (data not shown). This result
demonstrates that the S. maltophilia leader sequence can be recognized by E. coli and directs L1 for export in
the periplasm.

Figure 1. Localization of L1 produced in cells that contain the L1 gene and the leader sequence (FL-L1) and the L1
gene without the leader sequence (M-L1). (A) SDS−PAGE gel of periplasmic fractions of (left) E. coli cells
containing the gene for FL-L1 and (right) E. coli cells containing the gene for M-L1. The arrow marks the band for
L1. (B, C) Antibiotic selection assay. (B) E. coli cells on a LB−kanamycin plate containing the gene for L1 and the
leader sequence. (C) E. coli cells on a LB−kanamycin plate containing the gene for L1 without the leader
sequence. The white dots are the disks containing 10 μg of ampicillin.

To confirm this result, an antibiotic sensitivity assay was conducted. E. coli cells containing the overexpression
plasmids for M-L1 (Figure 1B) and FL-L1 (Figure 1C) were plated on LB plates containing kanamycin. Disks
containing 10 μg of ampicillin were placed on the plates, and the Petri dishes were incubated at 37 °C for 16 h.
The E. coli cells containing the gene for FL-L1 in pET26b grew well in the presence of ampicillin; however, those
cells containing the gene for M-L1 in pET26b did not grow in the area near the disk containing ampicillin. Since
ampicillin imparts its antibacterial activity in the periplasm, this result demonstrates that E. coli containing the
gene for FL-L1 exports L1 into the periplasm of the cell, while E. coli containing the gene for M-L1 does not.

Characterization of M-L1 and FL-L1
M-L1 and FL-L1 were overexpressed and purified as described by Crowder et al. (19). As previously
reported (19), purified FL-L1, which was overexpressed in LB medium, contained 1.9 equiv of Zn(II) and exhibited
steady-state kinetic constants of Km = 4 μM and kcat = 26 s−1 when using nitrocefin as the substrate (Table 1). In
contrast, M-L1, which was overexpressed in LB medium, bound 0.7 equiv of Fe and 0.6 equiv of Zn(II) (Table 2).
This enzyme exhibited a kcat of 10 s−1 and a Km of 1.0 μM when using nitrocefin as substrate. Clearly, the metal
content of L1 is greatly affected by where the protein is localized.
Table 1. Steady-State Kinetic and Metal Content Data for FL-L1a
enzyme
kcat (s−1) Km (μM) metal content (equiv)
FL-L1 with Mnb
13 ± 1
5±1
0.3 Mn/0.4 Fe/0.6 Zn(II)
FL-L1 with Zn(II)b
28 ± 2
6±1
0.1 Fe/1.9 Zn(II)
FL-L1 with Feb
3.6 ± 0.1 6 ± 1
0.9 Fe/0.3 Zn(II)
FL-L1 in LB mediumc
26 ± 1
4±1
1.9 ± 0.1 Zn(II)
FL-L1 in minimal mediumc 10 ± 1
4±1
0.4 Fe/0.3 Zn(II)
a
Substrate used in the kinetic studies was nitrocefin, and kinetic studies were conducted as described in
Materials and Methods.
b
L1 was overexpressed in minimal medium containing 50 μM of the indicated metal ion as described in Materials
and Methods.
c
L1 was overexpressed in minimal or LB medium without adding any additional metal ions.
Table 2. Steady-State Kinetic and Metal Content Data for L1 Folded in the Cytoplasm (M-L1)a
enzyme
kcat (s−1) Km (μM) metal content (equiv)
M-L1 with Mn(II)b
4.2 ± 0.4 2.1 ± 0.9 0.4 Mn; 0.4 Zn; 0.4 Fe
M-L1 with Zn(II)b
21 ± 1
7.0 ± 1.1 0.3 Fe; 1.2 Zn(II)
M-L1 with Fe(II)b
<0.1
N/A
1.5 Fe; 0.1 Zn(II)
M-L1 in minimal mediumc <0.1
N/A
0.2 Mn; 0.7 Fe; 0.1 Zn(II)
M-L1 in LB mediumc
10 ± 1
1.0 ± 0.2 0.7 Fe; 0.6 Zn(II)
a
Substrate used in the kinetic studies was nitrocefin, and kinetic studies were conducted as described in
Materials and Methods.
b
L1 was overexpressed in minimal medium containing 50 μM of the indicated metal ion as described in Materials
and Methods.
c
L1 was overexpressed in minimal or LB medium without adding any additional metal ions.
To probe further the relationship where a protein is localized and the resulting metal content of the purified
protein, FL-L1 and M-L1 were overexpressed in minimal medium in the presence of iron, zinc, or manganese. As
a control, the proteins were also overexpressed in minimal medium that had no added metal ions. When the

two proteins were overexpressed in minimal medium in the absence of added metal ions, FL-L1 contained 0.4
equiv of Fe and 0.3 equiv of Zn(II) and exhibited a kcat of 10 s−1 and a Km of 4 μM (Table 1), while M-L1 contained
0.2 equiv of Mn, 0.7 equiv of Fe, and 0.1 equiv of Zn(II) and exhibited no measurable catalytic activity (Table 2).
From minimal medium containing 50 μM Zn(II), FL-L1 contained 1.9 equiv of Zn(II) and 0.1 equiv of Fe and
exhibited a kcat of 28 s−1 and a Km of 6 μM (Table 1), while M-L1 contained 0.3 equiv of Fe and 1.2 equiv of Zn(II)
and exhibited a kcat of 21 s−1 and a Km of 7 μM (Table 2). From minimal medium that was made 50 μM in Fe(II),
FL-L1 contained 0.9 equiv of Fe and 0.3 equiv of Zn(II) and exhibited a kcat of 3.6 s−1 and a Km of 6 μM (Table 1),
while M-L1 contained 1.5 equiv of Fe and 0.1 equiv of Zn(II) and exhibited no measureable catalytic activity
(Table 2). Lastly, from minimal medium containing 50 μM Mn, FL-L1 contained 0.3 equiv of Mn, 0.4 equiv of Fe,
and 0.6 equiv of Zn(II) and exhibited a kcat of 13 s−1 and a Km of 5 μM (Table 1), while M-L1 contained 0.4 equiv of
Mn, 0.4 equiv of Zn(II), and 0.4 equiv of Fe and exhibited a kcat of 4.2 s−1 and a Km of 2.1 μM (Table 2). Mβl L1 can
bind a number of different metal ions, and the final metal content depends greatly on whether the protein is
exported and localized in the periplasm or whether it is localized in the cytoplasm.

Refolding L1 in the Presence of Different Divalent Metal Ions
The biological incorporation of metal ion experiments described above suggests that the bioavailability of metal
ions has a large effect on the metal content of L1 after purification. Even though the steady-state kinetic studies
demonstrated that L1 localized in the cytoplasm does have catalytic activity when bound to Zn(II), it is possible
that the different metal content of the M-L1 and FL-L1 may be due to different folding mechanisms in the
periplasm and cytoplasm. In an effort to probe whether bioavailability of metal ions does in fact affect metal
content, in vitro unfolding/refolding experiments were conducted.
Purified, apo-L1 was unfolded in the presence of 6 M Gdn-HCl and refolded in the presence of 50 μM Fe(II),
Mn(II), Zn(II), and Fe(II)/Zn(II) (Table 3). L1 refolded in the presence of Zn(II) was shown to bind 2 equiv of Zn(II)
and exhibited steady-state kinetic constants of kcat = 37 ± 1 s−1 and Km = 3.5 ± 0.2 μM when using nitrocefin as
substrate (Table 3). These values are very similar to those of FL-L1 (Table 1). L1 refolded in the presence of Fe(II)
resulted in an protein that binds 2 equiv of iron; however, the protein exhibited no catalytic activity. L1 refolded
in the presence of Mn(II) did not bind its full complement of metal (only 0.2 equiv), and this protein also did not
exhibit any catalytic activity. Since both Zn(II) and Fe appear to bind well to L1, we conducted a competition
study in which L1 (20 μM) was refolded in the presence of equimolar amounts (50 μM) of Fe(II) and Zn(II). The
resulting enzyme was shown to bind 1.5 equiv of Zn(II) and 0.4 equiv of Fe and exhibited steady-state kinetic
constants of kcat = 28 ± 1 s−1 and Km of 3.0 ± 0.2 μM. This result demonstrates that L1 “prefers” Zn(II) binding but
can also bind Fe.
Table 3. L1 Refolded in the Presence of Fe(II), Zn(II), and Mn(II)a
enzyme refolded kcat (s−1) Km (μM) metal content (equiv)
with Zn(II)
37 ± 1
3.5 ± 0.2 2.0 ± 0.1 Zn
with Fe(II)
<0.1
N/A
2.0 ± 0.1 Fe
with Mn(II)
<0.1
N/A
0.20 ± 0.05 Mn
with Zn(II) + Fe(II) 28 ± 1
3.0 ± 0.2 1.5 ± 0.1 Zn, 0.4 ± 0.1 Fe
a
Substrate used in the kinetic studies was nitrocefin, and kinetic studies were conducted as described in
Materials and Methods.

EPR Studies on Fe-Containing Forms of L1
EPR spectra of as-isolated M-L1, containing 0.7 equiv of Fe and 0.6 equiv of Zn(II), exhibited typical temperaturedependent features at geff values of 9.3 (745 G, 74.5 mT) and 4.3 (1616 G, 161.6 mT) due to transitions in the
ground state and middle Kramers’ doublets, respectively, of S = 5/2 Fe(III) (Figure 2A). An additional signal was

observed with geff < 2.0 and was assigned to an Fe(II)Fe(III) species on the basis of the similarity of the signal to
one from glyoxalase 2−5 (16). Similar signals have been reported for uteroferrin and mammalian purple acid
phosphatases (26, 27). This signal in M-L1 exhibited a complex temperature and power dependence and was
optimally developed at 10−12 K. Difference analysis indicated that the g < 2 signal was due to at least two
discrete but extremely similar species with slightly different spin Hamiltonian and relaxation parameters, due
either to discrete [Fea(II)Feb(III)] and [Fea(III)Feb(II)] species or to structural microheterogeneity. EPR of L1 that
was refolded in the presence of Fe(II) showed the same sets of S = 1/2 and S = 5/2 signals but in very different
proportions (Figure 2B). Because of the complex temperature dependence of the S = 1/2 signal and because of
the inherent complexity of the S = 5/2 “geff = 4.3” system (28), results of attempts at quantitation should be
treated with some caution; for signals of the quality obtained, an error of ±5% in spin concentration is expected,
and an additional error due to uncertainty in the respective zero-field splittings in the species is estimated be
±5%, leading to an overall error of ±10%. Nevertheless, the results of quantitation are enlightening as a
comparison tool. The EPR signal from as-isolated M-L1, containing both Fe and Zn(II), was estimated to be due to
a 45 ± 5% contribution of the Fe(III) signal and a 55 ± 5% contribution of the Fe(II)Fe(III) signal. In contrast, L1
refolded in the presence of iron exhibited a spectrum with >90% spin density due to the Fe(II)Fe(III) signal and
only 6−8% due to isolated S = 5/2 Fe(III). The total spin density of the refolded L1 corresponded to 0.8 equiv of
spins and, therefore, suggests that 0.8 × 90% ∼ 70% of the molecules contained an Fe(II)Fe(III) center. This, in
turn, suggests an overall Fe content of ∼1.55 ± 0.15 Fe/mol, which is in very good agreement with the analytical
value of 1.5 equiv of Fe/mol. Efforts to collect 1H NMR spectra of the iron-containing L1 samples have not been
successful as the proteins are not stable and precipitate during acquisition times.

Figure 2. (A) EPR spectra of as-isolated M-L1 recorded at 5.6 K, 63 mW (filled line), 12 K, 63 mW (dotted line),
and 12 K, 10 mW (dashed line). Various regions of the spectrum are shown to highlight the different behaviors
as a function of temperature and microwave power. (B) EPR spectrum of as-isolated L1, “FeZn-L1” (dotted line,
12 K, 10 mW), and that of L1 refolded in the presence of iron, “Fe-L1” (filled line; 10 mW, 10 K).

Zn(II) and Fe Content in E. coli
The studies above strongly suggest that the metal content of L1 is determined by the bioavailability of Fe and
Zn(II) where the protein is folded/localized. In an effort to evaluate the amount of Fe and Zn(II) in the periplasm
and cytoplasm of E. coli cells, we conducted metal analyses on the periplasmic and cytoplasmic fractions of E.
coli cells grown in minimal medium containing no additional metal ions and containing 100 μM Zn(II) or Fe. The
amount of Zn(II) and Fe in the soluble portion of the cytoplasm of E. coli cells cultured in the absence of added
metal ions is ca. 45 μM for both metal ions. If the cells are cultured in minimal medium containing 100 μM Zn(II)
or Fe, the amount of Zn(II) in the cytoplasm remains at 45 μM, while the amount of Fe increases 3-fold to about
153 μM. In the soluble periplasmic fractions, the amount of Zn(II) and Fe from cells cultured in the absence of
added metal ion is <1 μM. In the soluble periplasmic fraction of cells cultured in the presence of Zn(II) and Fe,
the amount of Zn(II) increased >10-fold to 1.23 mM, while the amount of Fe increased >20-fold to 2.83 mM. The
bioavailability of Zn(II) in the periplasm and the preference for Zn(II) binding to FL-L1 leads then to the
preparation of ZnZn-L1 when the protein is overexpressed in medium containing enough Zn(II). In the absence of
enough Zn(II), Fe can bind to L1 (in the cytoplasm and in the samples overexpressed with added Fe).

Discussion
While the number of Zn(II) ions physiologically bound to mβl’s is under debate (29-33), there is universal
agreement that Zn(II) is the metal ion bound to these enzymes in vivo. Nonetheless, several groups have
reported spectroscopic studies using Co(II) and Cd(II) analogues (29, 34-39) (both metal ions are excellent
surrogates of Zn(II)) of several mβl’s, and early papers on several mβl’s reported activation of apoenzymes by
manganese, iron, and other metal ions (40, 41). A recent paper by Vila and co-workers reports the binding of Fe
to GOB-1 from E. meningoseptica, although the resulting enzyme was catalytically inactive (33). Page and coworkers recently reported that manganese-substituted BcII exhibited catalytic activity (42). Since mβl’s are
enzymes that confer resistance to antimicrobial agents, it seems reasonable that the activation of these
enzymes by different metal ions, particularly in environments that lack sufficient quantities of Zn(II), would be
beneficial to the organism. There certainly is precedence in the literature for Zn(II) binding sites in Zn(II)
metalloenzymes being able to bind a number of different metal ions (14, 15), and a large of number of studies
on metal-substituted aminopeptidase from A. proteolytica have been reported (43-47). Nonetheless, it is not
clear that many of these metal-substituted enzymes are physiologically relevant. In the present study, we were
interested in determining whether the metal content of mβl L1 is affected by where the protein is
folded/metallated/localized.
We, therefore, prepared overexpression constructs that contained the full-length gene for L1 (leader sequence
plus gene for L1, FL-L1) or that contained only the gene for L1 (no leader sequence, M-L1) and used these
plasmids to overexpress L1. Our first task was to determine where L1 was localized in E. coli after protein
production, and our data clearly show that L1 produced from the FL-L1 plasmid is exported into the periplasm,
while L1 produced from the M-L1 plasmid is in the cytoplasm. The overexpression and localization of L1 in the
cytoplasm without a fusion peptide/protein are the first examples of a mature mβl being produced and localized
in the cytoplasm. Biochemical analyses of the two enzymes when overexpressed in rich medium clearly show
that the two enzymes are different, with FL-L1 binding only Zn(II) and M-L1 binding nearly equal amounts of Fe
and Zn(II). This latter result is similar to results previously reported for recombinant glyoxalase II, which is a
member of the β-lactamase superfamily of proteins (14, 15) and is overexpressed and localized in the cytoplasm
of E. coli.
The export of L1 into the periplasm could be accomplished by at least two different pathways. The first pathway
is the TAT system in E. coli, which transfers fully folded proteins from the cytoplasm into the periplasm (48). This
system requires the presence of an Arg-rich sequence in the protein that serves as a signaling sequence. Given

that L1 does not have this Arg-rich sequence (25) and that M-L1 and FL-L1 bind different metal ions, it is highly
unlikely that L1 is transported as a folded, metallated protein via the TAT system. The second major transport
system is the Sec system, which has been studied in detail (49). The Sec system exports unfolded proteins, and
therefore once in the periplasm, the periplasmic protein must be folded by folding proteins in the periplasm.
Moreover, periplasmic proteins must be metalated in the periplasm, and the metal content data presented in
this work support this pathway in use by L1.
To further probe how the metal content of L1 is affected by where the protein is folded and metalated, we
overexpressed and purified M-L1 and FL-L1 from minimal medium containing Fe, Zn(II), or Mn. The resulting
proteins contained different amounts of metal ions and exhibited different kinetic properties. The amount of
metal available for metalation of L1 is determined by the amount of the metal in the growth medium, no matter
if the protein is folded in the periplasm or cytoplasm. While the increase in bioavailability of a metal ion in the
periplasm as the metal concentration of the medium goes up was expected, the increase in bioavailable metal in
the cytoplasm was unexpected. All cells have elaborate homeostatic pathways that presumably maintain metal
ion concentrations in a very narrow range of concentrations (50-52). For example, the cytoplasmic
concentrations of Zn(II) are maintained by importers ZnuABC and ZupT and exporters ZitB and ZntA (53). Metal
analyses of the soluble periplasmic and cytoplasmic fractions of E. coli demonstrate that the concentrations of
metal ions in both fractions increase with increasing levels (only slightly so for Zn(II)) of the metal ion in the
growth medium. The relatively higher increase in cytoplasmic Fe levels may be due to the cell’s better ability to
store Fe rather than Zn(II) in bacterioferritin (54). The preparation of L1 that was folded and metalated in the
cytoplasm contains a different metal content, and this result indicates that caution should be exercised when
recombinant metalloproteins are overexpressed. Ideally, overexpression constructs should be made so that
bacterial metalloproteins will be overexpressed and folded in the same place in E. coli as they are folded in the
original organism. When overexpressing eukaryotic metalloproteins in E. coli, overexpression constructs should
be designed to fold/metalate the protein in the cytoplasm, periplasm, and/or possible in the extracellular
environment (using a pelB leader for example) so that the possibility of different metal content of the resulting
protein can be evaluated.
The overexpression of M-L1 in the cytoplasm yielded an analogue of L1 that contains nearly equimolar
concentrations of Fe and Zn(II). Given the trihistidine site in the Zn1 site of L1 (13), it was predicted that this
enzyme was a FeZn analogue of L1; however, EPR studies demonstrated that there is a mixture of metal centers
in this sample including a spin-coupled Fe(III)Fe(II) center and a Fe(III)Zn(II) center. Our ability to refold L1 in the
presence of Zn(II) and/or Fe allowed for us to obtain metal-enriched forms of L1. These data clearly show that
the FeFe analogue of L1 is inactive, possibly due to Asp120 bridging the metal centers (55, 56), which is probably
required for the observed antiferromagnetic coupling between the Fe ions (57), and not being available to form
an essential hydrogen bond with the bridging hydroxide (55). It is not clear from our data whether the
Fe(III)Zn(II) analogue of L1 is catalytically active, but the refolding of L1 in the presence of equimolar
concentrations of Fe and Zn(II) clearly shows a preference for Zn(II) binding to L1. Future studies will address
whether the Fe(III)Zn(II) analogue of L1 is catalytically active.
Taken together, this work demonstrates that the metal content of L1 depends strongly on bioavailability of
metal ions where the protein is folded. This result will aid in the preparation of metal-substituted
metalloproteins to study the structure/function of these proteins.

References
1 Crowder, M. W., Spencer, J., and Vila, A. J.2006 Metallo-β-lactamases: Novel weaponry for antibiotic
resistance in bacteria Acc. Chem. Res. 39 721 728

2 Walsh, T. R., Toleman, M. A., Poirel, L., and Nordmann, P.2005 Metallo-β-lactamases: the quiet before the
storm? Clin. Microbiol. Rev. 18 306 325
3 Georgopapadakou, N. H.2004 β-Lactamase inhibitors: evolving compounds for evolving resistance
targets Expert Opin. Invest. Drugs 13 1307 1318
4 Fisher, J. F., Meroueh, S. O., and Mobashery, S.2005 Bacterial resistance to β-lactam antibiotics: compelling
opportunism, compelling opportunity Chem. Rev. 105 395 424
5 Bebrone, C.2007 Metallo-β-lactamases (classification, activity, genetic organization, structure, zinc
coordination) and their superfamily Biochem. Pharmacol. 74 1686 1701
6 Toney, J. H., and Moloughney, J. G.2004 Metallo-β-lactamase inhibitors: promise for the future? Curr. Opin.
Invest. Drugs 5 823 826
7 Heinz, U., and Adolph, H. W.2004 Metallo-β-lactamases: two binding sites for one catalytic metal ion? CMLS,
Cell. Mol. Life Sci. 61 2827 2839
8 Knowles, J. R. (1980) in Enzyme Inhibitors (Brodbeck, U., Ed.) pp 163− 167, Verlag Chemie, Weinheim.
9 Park, H., Brothers, E. N., and Merz, K. M.2005 Hybrid QM/MM and DFT investigations of the catalytic
mechanism and inhibition of the dinuclear zinc metallo-β-lactamase CcrA from Bacteroides fragilis J. Am.
Chem. Soc. 127 4232 4241
10 Rasia, R. M., and Vila, A. J.2003 Mechanistic study of the hydrolysis of nitrocefin mediated by B.
cereus metallo-β-lactamase ARKIVOC 3 507 516
11 Oelschlaeger, P., Schmid, R. D., and Pleiss, J.2003 Insight into the mechanism of the IMP-1 metallo-βlactamase by molecular dynamics simulations Protein Eng. 16 341 350
12 Suarez, D., Brothers, E. N., and Merz, K. M.2002 Insights into the structure and dynamics of the dinuclear zinc
β-lactamase site from Bacteroides fragilis Biochemistry 41 6615 6630
13 Ullah, J. H., Walsh, T. R., Taylor, I. A., Emery, D. C., Verma, C. S., Gamblin, S. J., and Spencer, J.1998 The crystal
structure of the L1 metallo-β-lactamase from Stenotrophomonas maltophilia at 1.7 angstrom
resolution J. Mol. Biol. 284 125 136
14 Schilling, O., Wenzel, N., Naylor, M., Vogel, A., Crowder, M., Makaroff, C., and Meyer-Klaucke,
W.2003 Flexible metal binding of the metallo-β-lactamase domain: Glyoxalase II incorporates iron,
manganese, and zinc in vivo Biochemistry 42 11777 11786
15 Wenzel, N. F., Carenbauer, A. L., Pfiester, M. P., Schilling, O., Meyer-Klaucke, W., Makaroff, C. A.,
and Crowder, M. W.2004 The binding of iron and zinc to glyoxalase II occurs exclusively as di-metal
centers and is unique within the metallo-β-lactamase family J. Biol. Inorg. Chem. 9 429 438
16 Marasinghe, G. P. K., Sander, I. M., Bennett, B., Periyannan, G., Yang, K. W., Makaroff, C. A., and Crowder, M.
W.2005 Structural studies on a mitochondrial glyoxalase II J. Biol. Chem. 280 40668 40675
17 Gomes, C. M., Silva, G., Oliveira, S., LeGall, J., Liu, M. Y., Xavier, A. V., Rodrigues-Pousada, C., and Teixeira,
M.1997 Studies on the redox centers of the terminal oxidase from Desulfovibrio gigas and evidence for
its interaction with rubredoxin J. Biol. Chem. 272 22502 22508
18 Moran-Barrio, J., Gonzalez, J. M., Lisa, M. N., Costello, A. L., Peraro, M. D., Carloni, P., Bennett, B., Tierney, D.
L., Limansky, A. S., Viale, A. M., and Vila, A. J.2007 The metallo-β-lactamase GOB Is a mono-Zn(II) enzyme
with a novel active site J. Biol. Chem. 282 18286 18293
19 Crowder, M. W., Walsh, T. R., Banovic, L., Pettit, M., and Spencer, J.1998 Overexpression, purification, and
characterization of the cloned metallo-β-lactamase L1 from Stenotrophomonas maltophilia Antimicrob.
Agents Chemother. 42 921 926
20 Sigdel, T. K., Cilliers, R., Gursahaney, P. R., and Crowder, M. W.2004 Fractionation of soluble proteins
in Escherichia coli using DEAE-, SP-, and phenyl sepharose chromatographies J. Biomol. Tech. 15 199 207
21 Crowder, M. W., Maiti, M. K., Banovic, L., and Makaroff, C. A.1997 Glyoxalase II from A. thaliana requires
Zn(II) for catalytic activity FEBS Lett. 418 351 354
22 Purpero, V. M., and Moran, G. R.2006 Catalytic, noncatalytic, and inhibitory phenomena: kinetic analysis of
(4-hydroxyphenyl)pyruvate dioxygenase from Arabidopsis thaliana Biochemistry 45 6044 6055
23 Bou-Abdallah, F., and Chasteen, N. D.2008 Spin concentration measurements of high-spin (g′=4.3) rhombic
iron(III) ions in biological samples: theory and application J. Biol. Inorg. Chem. 13 15 24

24 Aasa, R., and Vanngard, T.1975 EPR signal intensity and powder shapes: A reexamination J. Magn.
Reson. 19 308 315
25 Walsh, T. R., Hall, L., Assinder, S. J., Nichols, W. W., Cartwright, S. J., MacGowan, A. P., and Bennett, P.
M.1994 Sequence analysis of the L1 metallo-β-lactamase from Xanthomonas maltophilia Biochim.
Biophys. Acta 1218 199 201
26 Crowder, M. W., Vincent, J. B., and Averill, B. A.1992 Electron paramagnetic resonance studies on the highsalt form of bovine spleen purple acid phosphatase Biochemistry 31 9603 9608
27 David, S. S., and Que, L.1990 Anion binding to uteroferrin. Evidence for phosphate coordination to the
iron(III) ion of the dinuclear active site and interaction with the hydroxo bridge J. Am. Chem.
Soc. 112 6455 6463
28 Copik, A. J., Waterson, S., Swierczek, S. I., Bennett, B., and Holz, R. C.2005 Both nucleophile and substrate
bind to the catalytic Fe(II)-center in the type II methionyl aminopeptidase from Pyrococcus
furiosus Inorg. Chem. 44 1160 1162
29 Badarau, A., Damblon, C., and Page, M. I.2007 The activity of the dinuclear cobalt-β-lactamase from Bacillus
cereus in catalysing the hydrolysis of β-lactams Biochem. J. 401 197 203
30 Badarau, A., and Page, M. I.2006 Enzyme deactivation due to metal ion dissociation during turnover of the
cobalt-β-lactamase catalyzed hydrolysis of β-lactams Biochemistry 45 11012 11020
31 Wommer, S., Rival, S., Heinz, U., Galleni, M., Frere, J. M., Franceschini, N., Amicosante, G., Rasmussen,
B., Bauer, R., and Adolph, H. W.2002 Substrate-activated zinc binding of metallo-β-lactamases—
Physiological importance of the mononuclear enzymes J. Biol. Chem. 277 24142 24147
32 Gonzalez, J. M., Medrano Martin, F. J., Costello, A. L., Tierney, D. L., and Vila, A. J.2007 The Zn2 position in
metallo-β-lactamases is critical for activity: a study on chimeric metal sites on a conserved protein
scaffold J. Mol. Biol. 373 1141 1156
33 Moran-Barrio, J., Gonzalez, J. M., Lisa, M. N., Costello, A. L., Dal Peraro, M., Carloni, P., Bennett, B., Tierney, D.
L., Limansky, A. S., Viale, A. M., and Vila, A. J.2007 The metallo-β-lactamase GOB is a mono-Zn(II) enzyme
with a novel active site J. Biol. Chem. 282 18286 18293
34 Periyannan, G., Costello, A. L., Tierney, D. L., Yang, K. W., Bennett, B., and Crowder, M. W.2006 Sequential
binding of cobalt(II) to metallo-β-lactamase CcrA Biochemistry 45 1313 1320
35 Crawford, P. A., Yang, K. W., Sharma, N., Bennett, B., and Crowder, M. W.2005 Spectroscopic studies on
cobalt(II)-substituted metallo-β-lactamase ImiS from Aeromonas veronii bv.
sobria Biochemistry 44 5168 5176
36 Paul-Soto, R., Zeppezauer, M., Adolph, H. W., Galleni, M., Frere, J. M., Carfi, A., Dideberg, O., Wouters,
J., Hemmingsen, L., and Bauer, R.1999 Preference of Cd(II) and Zn(II) for the two metal sites in Bacillus
cereus β-lactamase II: A perturbed angular correlation of γ-rays spectroscopic
study Biochemistry 38 16500 16506
37 Paul-Soto, R., Bauer, R., Frere, J. M., Galleni, M., Meyer-Klaucke, W., Nolting, H., Rossolini, G. M., de Seny,
D., Hernandez-Villadares, M., Zeppezauer, M., and Adolph, H. W.1999 Mono- and binuclear Zn2+ βlactamase J. Biol. Chem. 274 13242 13249
38 Wang, Z., and Benkovic, S. J.1998 Purification, characterization, and kinetic studies of soluble Bacteroides
fragilis metallo-β-lactamase J. Biol. Chem. 273 22402 22408
39 Paul-Soto, R., Hernandez-Valladares, M., Galleni, M., Bauer, R., Zeppezauer, M., Frere, J. M., and Adolph, H.
W.1998 Mono- and binuclear Zn- β-lactamase from Bacteroides fragilis: Catalytic and structural roles of
the zinc ions FEBS Lett. 438 137 140
40 Saino, Y., Kobayashi, F., Inoue, M., and Mitsuhashi, S.1982 Purification and properties of inducible penicillin
β-lactamase isolated from Pseudomonas maltophilia Antimicrob. Agents Chemother. 22 564 570
41 Sato, K., Fujii, T., Okamoto, R., Inoue, M., and Mitsuhashi, S.1985 Biochemical properties of β-lactamase
produced by Flavobacterium odoratum Antimicrob. Agents Chemother. 27 612 614
42 Badarau, A., and Page, M. I.2006 The variation of catalytic efficiency of Bacillus cereus metallo-β-lactamase
with different active site metal ions Biochemistry 45 10654 10666

43 Bennett, B., Antholine, W. E., D’Souza, V. M., Chen, G. J., Ustinyuk, L., and Holz, R. C.2002 Structurally distinct
active sites in the copper(II)-substituted aminopeptidases from Aeromonas proteolytica and Escherichia
coli J. Am. Chem. Soc. 124 13025 13034
44 Bennett, B., and Holz, R. C.1997 Spectroscopically distinct cobalt(II) sites in heterodimetallic forms of the
aminopeptidase from Aeromonas proteolytica: Characterization of substrate
binding Biochemistry 36 9837 9846
45 Bienvenue, D. L., Mathew, R. S., Ringe, D., and Holz, R. C.2002 The aminopeptidase from Aeromonas
proteolytica can function as an esterase J. Biol. Inorg. Chem. 7 129 135
46 D’Souza, V. M., Swierczek, S. I., Cosper, N. J., Meng, L., Ruebush, S., Copik, A. J., Scott, R. A., and Holz, R.
C.2002 Kinetic and structural characterization of manganese(II) loaded methionyl
aminopeptidase Biochemistry 41 13096 13105
47 D’Souza, V. M., Bennett, B., Copik, A. J., and Holz, R. C.2000 Divalent metal binding properties of the
methionyl aminopeptidase from Escherichia coli Biochemistry 39 3817 3826
48 Gohlke, U., Pullan, L., McDevitt, C. A., Porcelli, I., de Leeuw, E., Palmer, T., Saibil, H. R., and Berks, B.
C.2005 The TatA component of the twin-arginine protein transport system forms channel complexes of
variable diameter Proc. Natl. Acad. Sci. U.S.A. 102 10482 10486
49 Driessen, A. J. M., Fekkes, P., and van der Wolk, J. P. W.1998 The Sec system Curr. Opin. Microbiol. 1 216 222
50 Andrews, S. C., Robinson, A. K., and Rodriguez-Quinones, F.2003 Bacterial iron homeostasis FEMS Microbiol.
Rev. 27 215 237
51 Moore, C. M., and Helmann, J. D.2005 Metal ion homeostasis in Bacillus subtilis Curr. Opin.
Microbiol. 8 188 195
52 Solioz, M., and Stoyanov, J. V.2003 Copper homeostasis in Enterococcus hirae FEMS Microbiol.
Lett. 27 183 195
53 Chimienti, F., Aouffen, M., Favier, A., and Seve, M.2003 Zinc homeostasis-regulating proteins: New drug
targets for triggering cell fate Curr. Drug Targets 4 323 338
54 Andrews, S. C.1998 Iron storage in bacteria Adv. Microb. Physiol. 40 281 351
55 Garrity, J. D., Carenbauer, A. L., Herron, L. R., and Crowder, M. W.2004 Metal binding Asp-120 in metallo-βlactamase L1 from Stenotrophomonas maltophilia plays a crucial role in catalysis J. Biol.
Chem. 279 920 927
56 Crisp, J., Conners, R., Garrity, J. D., Carenbauer, A. L., Crowder, M. W., and Spencer, J.2007 Structural basis for
the role of Asp-120 in metallo-β-lactamases Biochemistry 46 10664 10674
57 Vincent, J. B., Olivier-Lilley, G. L., and Averill, B. A.1990 Proteins containing oxo-bridged dinuclear iron
centers: A bioinorganic perspective Chem. Rev. 90 1447 1467

